Claire Drolen
University of California, Los Angeles(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Viral-associated cancers and disorders, Chronic Lymphocytic Leukemia Research, Palliative Care and End-of-Life Issues
Most-Cited Works
- → Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death(2016)129 cited
- → Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium(2023)62 cited
- → The Potential Revolution of Cancer Treatment with CRISPR Technology(2023)60 cited
- → Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches(2021)36 cited
- → pH-Driven Mechanistic Switching from Electron Transfer to Energy Transfer between [Ru(bpy)3]2+ and Ferrocene Derivatives(2018)23 cited
- → Surrogate Perspectives on Patient Preference Predictors: Good Idea, but I Should Decide How They Are Used(2022)13 cited
- → Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States(2024)12 cited
- → Impact of the elimination of the donation service area on United States lung transplant practices and outcomes at high and low competition centers(2020)9 cited
- → The Effect of Peer Review on the Quality of Data Graphs in Annals of Emergency Medicine(2016)4 cited
- → 437 Safety and efficacy of immune checkpoint inhibitors (ICI) in patients living with HIV (PLWH) and metastatic non-small cell lung cancer (NSCLC): a matched cohort study from the international CATCH-IT consortium(2022)2 cited